Am I a Candidate for Ketamine Therapy?

"Am I a candidate for ketamine therapy?" is usually one of the first questions people ask before ever booking a consultation, and it doesn't have a one-line answer. Eligibility depends on diagnosis, treatment history, current health conditions, and the medications already in your system — which is why clinics run a structured medical and psychiatric screening rather than handing out treatment on request. This guide covers who clinics typically consider good candidates, the contraindications of ketamine that rule some people out or call for extra caution, medication interactions worth disclosing, what the screening process actually involves, and whether ketamine therapy is legal. None of it replaces an actual evaluation — it's meant to help you walk into that first conversation already knowing what a licensed clinician is looking for.

Common Reasons People Seek Out Ketamine Therapy

The reasons for ketamine therapy usually come down to one thing: standard treatment hasn't worked, or hasn't worked well enough. Most patients arrive after trying one or more antidepressants, a course of talk therapy, or standard pain management without getting the relief they needed, and they're looking for an option with a different mechanism and a faster onset than typical oral antidepressants. Others are referred specifically because their diagnosis — treatment-resistant depression, severe anxiety, PTSD, or a chronic pain condition — has research behind ketamine's use when conventional options have been exhausted. A smaller group is referred in the context of acute suicidal ideation, where ketamine or Spravato's rapid-acting effect is used as part of a monitored clinical response rather than as standalone crisis care. None of these reasons guarantee eligibility on their own — they explain why someone ends up in a clinic's waiting room, not whether that clinic will ultimately treat them.

Who Clinics Typically Consider Good Candidates

There's no single profile of a good candidate for ketamine therapy, but a few patterns show up consistently across clinics:

• Treatment-resistant depression (TRD):the best-established use case, generally defined as depression that hasn't adequately improved after two or more different antidepressant trials at an appropriate dose and duration. See ketamine for treatment-resistant depression for how clinics define and evaluate that history.
• Severe anxiety or PTSDthat hasn't responded adequately to first-line medications and therapy, evaluated on a case-by-case basis since the evidence base here is thinner than for depression.
• Chronic pain conditionssuch as complex regional pain syndrome or certain neuropathic pain diagnoses, typically after standard pain management hasn't provided adequate relief.
• Acute suicidal ideation, in a monitored clinical setting.Esketamine (Spravato) has FDA approval specifically for depressive symptoms with suicidal ideation or behavior, administered under direct in-clinic supervision as part of a broader treatment plan — never as an unsupervised or standalone intervention. If you're in crisis right now, call or text 988 rather than waiting for a clinic appointment.

Being a good fit on paper still depends on the contraindications below. A prescriber weighs your diagnosis and treatment history against your overall health picture before confirming eligibility — the two questions are related but separate.

Absolute Contraindications of Ketamine Therapy

A contraindication of ketamine is a health condition that a clinic treats as a reason not to proceed, at least not without addressing the underlying issue first. The conditions most consistently flagged as absolute or near-absolute exclusions include:

• Uncontrolled or severe hypertension.Ketamine reliably raises blood pressure and heart rate during dosing, so a baseline that's already dangerously high is a standard screen-out until it's brought under control.
• Unstable cardiovascular disease — a recent heart attack, unstable angina, certain arrhythmias, or a known aneurysm, since the cardiovascular stress of dosing can be risky on top of an already unstable heart condition.
• A personal history of psychosis or schizophrenia.Ketamine's dissociative effect can be destabilizing for someone with an underlying psychotic disorder, and most clinics treat this as a firm exclusion rather than a caution.
• Active mania, in bipolar disorder or otherwise, since the dissociative and mood-elevating effects can worsen an active manic episode.
• Pregnancy or breastfeeding.Ketamine crosses the placenta and passes into breast milk, so it's not offered to patients who are pregnant, trying to become pregnant, or nursing.
• A known allergy or hypersensitivity to ketamine.
• Elevated intracranial or intraocular pressure — conditions like uncontrolled glaucoma or a history of significantly raised pressure in the brain, since ketamine can raise both further.

This list reflects what shows up most often across clinic intake criteria and the anesthesia literature ketamine's safety profile is built on, not a single official standard every clinic follows word for word. Two clinics can weigh a borderline case differently, which is exactly why a real medical review matters more than a self-check against a list.

Relative Contraindications and Conditions That Need Extra Caution

Some conditions don't automatically rule someone out but do change how a clinic approaches treatment — more monitoring, a modified dose, or a required consult with another specialist first:

• A history of substance use disorder, including with ketamine itself. Active, uncontrolled use is typically an exclusion; a stable history in recovery is evaluated individually, often with added structure such as more frequent check-ins or a required support person.
• Significant untreated liver disease, since the liver processes ketamine and impaired function can change how the drug clears the body.
• Well-controlled but still present cardiac risk factors — managed hypertension, a stable arrhythmia, or older cardiac history that a cardiologist has since cleared — where treatment may still proceed with closer vital-sign monitoring.
• A family history of psychosis or bipolar disorder,without a personal diagnosis, which some clinics ask about even though it doesn't carry the same weight as a personal history.
• Significant untreated anxiety about the dissociative experience itself, which a clinic may address through a lower starting dose or extra preparation rather than declining treatment outright.

The line between an absolute and a relative contraindication isn't always crisp in practice, and a condition on this list doesn't automatically mean no. It means the conversation with your prescriber needs to go deeper before either of you decides.

Medication and Substance Interactions Clinics Ask About

Eligibility isn't only about diagnoses — what you're already taking matters just as much, and a full medication list is one of the most consequential things you bring to intake.

• Benzodiazepines,such as Xanax, Klonopin, or Ativan, are worth flagging specifically. Some research suggests concurrent benzodiazepine use may blunt or delay ketamine's antidepressant response, and combining the two also adds to sedation during dosing. That doesn't automatically disqualify a patient who takes one regularly, but a clinic may ask about timing benzodiazepine doses around sessions — never something to change on your own without medical guidance, since stopping a benzodiazepine abruptly carries its own risks.
• Lamotrigine,a mood stabilizer and anticonvulsant, works partly by reducing glutamate release — the same neurotransmitter system ketamine is thought to act through — so some clinicians ask whether it may dampen ketamine's subjective or therapeutic effect. This is an area of ongoing discussion rather than settled practice, and it's a reasonable thing to raise with your prescriber rather than adjust yourself.
• MAOIs and lithium are commonly asked about during the initial screening call because of interaction and safety concerns specific to those medications.
• Alcohol and other sedatives around the time of a session add to grogginess and impaired coordination, which is part of why every legitimate clinic requires a sober driver and asks about recent use.

The safest approach is the simplest one: disclose everything you take — prescriptions, over-the-counter medications, and supplements — and let the prescribing clinician decide what, if anything, needs to change. Leaving something off the list because it seems unrelated is one of the more avoidable ways a treatment plan goes sideways.

What the Screening Process Actually Looks Like

Prescribing ketamine for an off-label mental-health or pain indication is a clinical judgment call, which is why the intake process is more thorough than a typical first doctor's visit. Expect a health history questionnaire covering every condition above, a full medication and supplement list, a review of past psychiatric diagnoses and treatments tried, baseline vital signs, and — especially for IV protocols or patients with cardiac risk factors — sometimes a recent EKG. Many clinics also use standardized symptom scales, like the PHQ-9 for depression or the PCL-5 for PTSD, to document a baseline before treatment starts. Our guide to what happens at your first ketamine therapy session walks through that full intake sequence, and our guide to ketamine safety and side effects covers the monitoring standards a legitimate clinic should meet once you're cleared to start.

Screening quality varies more between clinics than most patients expect — outside of Spravato's FDA-mandated REMS program, there's no single federal certification specific to ketamine treatment. A thorough intake that asks about everything above is one of the clearest signs a provider takes safety seriously; a clinic that skips straight to scheduling without it is worth a second look. It's worth reading how to verify a ketamine provider before you book, so you know what licensure and monitoring to confirm rather than taking a website's word for it.

Is Ketamine Therapy Legal?

Yes. Ketamine is a Schedule III controlled substance in the US, which means it's legal for a licensed prescriber to administer or prescribe it, including off-label for mental health or pain conditions — off-label prescribing itself is a routine, legal part of medical practice, not a loophole. Spravato (esketamine) is FDA-approved outright for treatment-resistant depression and for depressive symptoms with suicidal ideation, and it can only be given at a REMS-certified clinic under direct observation. What actually varies is telehealth policy: some states place tighter restrictions than others on prescribing a controlled substance without an in-person evaluation, and those rules have shifted more than once in recent years as federal telehealth flexibilities are extended, narrowed, or made permanent. Because those rules keep changing, confirm the current policy directly with a clinic in your state rather than assuming a rule you read previously still holds.

Once you've worked through the eligibility questions above, the practical next step is finding a properly licensed provider. You can browse ketamine clinics by state to compare providers, treatment formats, and published pricing before booking a consultation.

Frequently Asked Questions

None of this is a substitute for an actual medical and psychiatric evaluation. It's meant to help you understand what a licensed clinician is screening for, so your first consultation is a more informed conversation rather than a cold start.

Informational only — not medical advice. Eligibility for ketamine therapy can only be determined by a licensed clinician who has reviewed your full medical and psychiatric history. If you're in crisis, call or text 988.